Skip to main content
. 2024 Mar 18;15:76. doi: 10.1186/s13244-024-01645-4

Table 2.

Descriptive statistics for all 26 patients

Age (years) 52.0 ± 12.2 (range 31–75)
Location
 Left 17
 Right 9
MR
 a1 (cm) 1.488 ± 0.255 (range 1.1–1.9)
 b1 (cm) 1.219 ± 0.325 (range 0.5–1.9)
 ER positive 23
 PR positive 17
 HER2 positive 6
 High expression of Ki67 13
Molecular subtype
 Luminal A 12
 Luminal B (HER2 negative) 6
 Luminal B (HER2 positive) 5
 HER2 enriched (nonluminal) 1
 Triple negative 2

Except for age and MR, the data are the number of patients

Luminal A: estrogen receptor (ER) and progesterone receptor (PR) positive, Ki67 level less than 20%, HER2 negative. Luminal B (HER2 negative): ER positive and HER2 negative (PR < 20% or Ki67 ≥ 20%). Luminal B (HER2 positive): ER and HER2 positive (PR < 20% or Ki67 ≥ 20%). HER2 enriched (nonluminal): ER and PR negative and HER2 positive. Triple negative: ER, PR, and HER2 negative